A
Alnylam Pharmaceuticals, Inc. (ALNY)
NMS – Real vaqt narxi. Valyuta: USD
291.37
-1.80 (-0.61%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
291.14
-0.23 (-0.08%)
Bozordan keyin: Jun 26, 2026, 6:19 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
291.37
-1.80 (-0.61%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
291.14
-0.23 (-0.08%)
Bozordan keyin: Jun 26, 2026, 6:19 PM EDT
This stock has a consensus price target of $461.00 based on the ratings of 32 analysts. The high is $583.00 and the low is $310.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 310 | $ 461 | $ 583 |
| O’zgarish | 5.74% | 57.25% | 98.86% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-06-04 | 75.04% | HC Wainwright & Co. | $510 → $510 | Reiterates | Buy |
| 2026-05-19 | 30.42% | Citigroup | $380 | Initiates Coverage On | Buy |
| 2026-05-05 | 75.04% | HC Wainwright & Co. | $510 → $510 | Reiterates | Buy |
| 2026-05-01 | 52.73% | RBC Capital | $450 → $445 | Maintains | Outperform |
| 2026-05-01 | 29.39% | Wells Fargo | $376 → $377 | Maintains | Equal-Weight |